TYK-ed off by rosacea: an Australian case series of rosacea associated with deucravacitinib
Clinical and Experimental Dermatology · 2025
DOI: 10.1093/ced/llaf418 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical and Experimental Dermatology, 2025. Verfasst von Zachary Warren und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Monash Health, Melbourne, VIC, Australia. Hauptthemen laut MEDLINE: Rosacea, Protein Kinase Inhibitors, TYK2 Kinase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
Deucravacitinib is a novel oral selective tyrosine kinase 2 inhibitor used to treat plaque psoriasis. The most common cutaneous adverse effects are acne and folliculitis. We present a series of seven patients with prototypical papulopustular rosacea (PPR) following commencement of deucravacitinib. Although most of our patients demonstrated improvement in psoriasis on deucravacitinib, all seven patients discontinued therapy because of the severity and impact of PPR. Rosacea can be a severe adverse effect of deucravacitinib, impacting tolerability and influencing future treatment options.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Monash Health, Melbourne, VIC, Australia.
- Vital Dermatology, Adelaide, SA, Australia.
- Department of Dermatology, Flinders Medical Centre, Adelaide, SA, Australia.
- Central Dermatology Clinic, Maroochydore, QLD, Australia.
- Department of Dermatology, Skin Health Institute, Melbourne, VIC, Australia.
ORCID-Profile: Zachary Warren, Chloe West, Francis Yi Xing Lai
Zitieren
APA
Warren, Z., West, C., Sander, C., & Lai, F. Y. X. (2025). TYK-ed off by rosacea: an Australian case series of rosacea associated with deucravacitinib. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llaf418
Vancouver
Warren Z, West C, Sander C, Lai FYX. TYK-ed off by rosacea: an Australian case series of rosacea associated with deucravacitinib. Clinical and Experimental Dermatology. 2025. doi:10.1093/ced/llaf418
BibTeX
@article{Warren2025,
author = {Warren, Zachary and West, Chloe and Sander, Christina and Lai, Francis Yi Xing},
title = {TYK-ed off by rosacea: an Australian case series of rosacea associated with deucravacitinib},
journal = {Clinical and Experimental Dermatology},
year = {2025},
doi = {10.1093/ced/llaf418}
}
EUVIMED